Simultaneous Therapy With Intravitreal Dexamethasone Implant and Bevacizumab for the Treatment of Macular Edema

Sponsor
Retina Clinic, Sao Paulo, Brazil
Study ID
NCT02623673
Status
Completed

Conditions

  • Macular Edema

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

Retrospective cases series is a non-randomized, open-label, single-center investigation (Retina Clinic, São Paulo, Brazil) of patients diagnosed with macular edema secondary to diabetic retinopathy (DME) and retinal vein occlusions who underwent to simultaneous treatment with intravitreal injection of bevacizumab 1.25mg and implant of dexamethasone 0.7mg.

Key Dates

First listed
Dec 8, 2015
Start date
Sep 30, 2015
Status verified
Feb 2016
Primary completion
Dec 31, 2015
Completion
Feb 29, 2016

Study Design

Enrollment
20 participants (actual)

Arms

  • Arm: bevacizumab plus dexamethasone 0.7mg
    simultaneous treatment with intravitreal injection of bevacizumab 1.25mg and intravitreal implant of dexamethasone 0.7mg

Primary Outcome Measure

Improvement in BCVA [ Time Frame: 6 months ]

Related Studies